Pentoxifylline inhibits interleukin-2-induced toxicity in C57BL/6 mice but preserves antitumor efficacy. - Wikidata - awgldk - TriplyDB

Pentoxifylline inhibits interleukin-2-induced toxicity in C57BL/6 mice but preserves antitumor efficacy.

Pentoxifylline inhibits interleukin-2-induced toxicity in C57BL/6 mice but preserves antitumor efficacy.

http://www.wikidata.org/entity/Q33370145

about

Improved IL-2 immunotherapy by selective stimulation of IL-2 receptors on lymphocytes and endothelial cells The tetravalent guanylhydrazone CNI-1493 blocks the toxic effects of interleukin-2 without diminishing antitumor efficacy Therapeutic activity of NK cells against tumors.Potential use of IL-2/anti-IL-2 antibody immune complexes for the treatment of cancer and autoimmune disease.The role of cytokines, adhesion molecules, and chemokines in interleukin-2-induced lymphocytic infiltration in C57BL/6 mice.Synergistic immunologic targets for the treatment of prostate cancer.Biological activities of hematopoietic growth factors that lead to future clinical application.Effects of methylxanthine derivatives on adriamycin concentration and antitumor activity.

P2860

Q33977597-B2098588-FD5E-41B1-81C1-5F498C1BEB0A Q34463802-4C21BEDE-29D6-4375-AEFE-459C3C76C122 Q34552162-1CFC53EF-F215-4FC8-8B8D-77F22F15E7A2 Q36708311-F9070696-FB5F-422E-8168-F08111EE4FFF Q37354383-85C81CEA-812E-4FA4-B874-400C2324D79C Q38904873-A3FE8851-DE6C-4DD0-A274-AB3E23484E6B Q40630439-D7A597AE-1235-41C1-A472-13CB80ABB4F2 Q43759505-2C999AE3-A7B0-48C9-B3C5-FC66FE36BD62

P2860

Pentoxifylline inhibits interleukin-2-induced toxicity in C57BL/6 mice but preserves antitumor efficacy.

http://www.wikidata.org/entity/Q33370145

description

1992 nî lūn-bûn

@nan

1992 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

1992 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

1992年の論文

@ja

1992年論文

@yue

1992年論文

@zh-hant

1992年論文

@zh-hk

1992年論文

@zh-mo

1992年論文

@zh-tw

1992年论文

@wuu

name

Pentoxifylline inhibits interl ...... preserves antitumor efficacy.

@ast

Pentoxifylline inhibits interl ...... preserves antitumor efficacy.

@en

type

label

Pentoxifylline inhibits interl ...... preserves antitumor efficacy.

@ast

Pentoxifylline inhibits interl ...... preserves antitumor efficacy.

@en

prefLabel

Pentoxifylline inhibits interl ...... preserves antitumor efficacy.

@ast

Pentoxifylline inhibits interl ...... preserves antitumor efficacy.

@en

P1433

Q33370145-083E0E73-B03A-42BE-9072-003875B65FFB

P1476

Q33370145-EE2D8F94-B3F6-4199-8EF5-0A86C5F0FEF6

P2093

Q33370145-A063F466-0DF6-4AD6-904D-56162A7FA3DF

Q33370145-AB14D394-A7EA-4E7D-85D8-CAE862F067D8

Q33370145-CB7BD146-2ABD-4460-A57D-931921724369

Q33370145-E5784894-8340-4102-819E-71D204A92B6D

Q33370145-E7FACE70-294A-4E8B-9C24-6910B0470F41

P2860

Q33370145-0CFD26AB-B1EA-41D8-8E6E-BD21817192BE

Q33370145-111DCCDE-A759-4E4B-A2DE-DC6809E2A2D3

Q33370145-655F28FD-41A1-427A-8F7D-B2F9E789A32C

Q33370145-9DE82A46-0327-4B55-BB1B-93ABB7D3B08E

Q33370145-A7631E69-E88E-4C35-97F6-B348154B4CBF

Q33370145-A934CF4F-4F4B-41F4-91C5-FEE9717D313A

Q33370145-ADCFB568-5464-4573-AB2F-7D9B843F9C99

Q33370145-D10E93C0-E6EA-4834-B5C1-D591A89F1951

Q33370145-DAD7D540-59A6-4CA5-B21C-7BC6FE14CAE2

Q33370145-E14E2FA5-0694-4AAF-AB3B-C63F4D6EED54

P304

Q33370145-D667B798-F519-4858-BBD0-B5367786009F

P31

Q33370145-FC493AE5-CA76-4014-9B63-2F2BD21B7FD9

P356

Q33370145-BF213C1F-8CE8-4B28-9A3F-E278818DD97B

P407

Q33370145-7F7E0853-18F1-4264-876B-621F0595144D

P433

Q33370145-1FF2D9EE-C017-4E8C-B541-F4F9BB1D2F3D

P478

Q33370145-87D4A513-D12A-4FD0-958E-CD6F97B0F7B0

P577

Q33370145-76771625-7C67-422F-9E71-E3AA76A7946B

P698

Q33370145-1F254C35-93B6-4A7F-ADB3-B0AFDAEED884

P932

Q33370145-CCD3D001-4321-47B7-8376-82BC0B80595A

P356

P1433

Journal of Clinical Investigation

P1476

Pentoxifylline inhibits interl ...... preserves antitumor efficacy.

@en

P2093

Doak KW

http://www.w3.org/2001/XMLSchema#string

Edwards MJ

http://www.w3.org/2001/XMLSchema#string

Heniford BT

http://www.w3.org/2001/XMLSchema#string

Klar EA

http://www.w3.org/2001/XMLSchema#string

Miller FN

http://www.w3.org/2001/XMLSchema#string

P2860

Toxicity of human recombinant interleukin-2 in the mouse is mediated by interleukin-activated lymphocytes. Separation of efficacy and toxicity by selective lymphocyte subset depletion.

Tumor necrosis factor alpha-induced pulmonary vascular endothelial injury.

Tumor necrosis factor and the acute metabolic response to tissue injury in man

Passive immunization against tumor necrosis factor partially abrogates interleukin 2 toxicity.

Interleukin-2 toxicity.

Cytotoxic mechanism of tumor necrosis factor-alpha.

Induction of circulating tumor necrosis factor (TNF alpha) as the mechanism for the febrile response to interleukin-2 (IL-2) in cancer patients.

In vivo administration of purified human interleukin 2. II. Half life, immunologic effects, and expansion of peripheral lymphoid cells in vivo with recombinant IL 2.

Pentoxifylline inhibits interleukin-2-induced leukocyte-endothelial adherence and reduces systemic toxicity.

Interleukin 2 induces tumor necrosis factor gene expression in vivo.

P304

637-641

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI115904

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

90

http://www.w3.org/2001/XMLSchema#string

P577

1992-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

1644928

http://www.w3.org/2001/XMLSchema#string

P932

443144

http://www.w3.org/2001/XMLSchema#string